cost effectiveness of frontline therapies for metastatic pancreatic cancer
Published 10 years ago • 368 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
7:26
case study: frontline treatment of metastatic pancreatic cancer
-
0:52
dr. cohn on frontline therapies in metastatic pancreatic cancer
-
7:14
metastatic pancreatic cancer: dosing strategies in the frontline setting
-
7:27
frontline decisions in metastatic pancreatic cancer
-
38:24
current and future directions in metastatic pancreatic cancer
-
0:57
dr. pant on choosing therapy for frontline and beyond in pancreatic cancer
-
2:57
frontline options for the treatment of pancreatic cancer
-
5:52
choosing upfront therapy for metastatic pancreatic cancer
-
7:54
advanced pancreatic cancer: deciding among frontline standards of care
-
9:08
folfirinox in metastatic pancreatic cancer
-
6:39
emerging therapies and novel targets in pancreatic cancer
-
9:20
precision medicine for pancreatic cancer
-
47:16
“molecular treatment frontiers for rcc” and “utility and cost-effectiveness of psma-pet”
-
7:19
novel treatment strategies explored in pancreatic cancer
-
1:15
optimizing first line treatment in metastatic pancreatic cancer
-
5:01
folfirinox-based regimens for pancreatic cancer
-
2:52
new drug development needed in pancreatic cancer
-
15:03
survival & cost-effectiveness & impact of positive clinical trials in the management of hcc in asia
-
0:31
medical myth - there is only one kind of pancreatic cancer. 3